KL Business Summary

KL (6431.TW), officially known as Guangli Biotech Holding Co., Ltd. (光麗-KY), operates a business model centered on the research, development, and distribution of functional skincare products and medical beauty solutions. The company generates revenue primarily through two segments: its professional medical beauty division, which supplies aesthetic clinics with specialized equipment and consumables, and its consumer skincare division, which manages proprietary brands across retail and e-commerce platforms in the Greater China region. Having successfully pivoted from its legacy in LED automotive lighting, KL now focuses on high-margin biotechnology applications and functional cosmetics. In the competitive landscape of the Taiwan and mainland Chinese aesthetic markets, KL competes directly with industry leaders such as TCI Co., Ltd. (8436.TW), Dr. Wu Skincare (6523.TWO), and Chlitina Holding Limited (4137.TW). KL positions itself as a vertically integrated boutique provider, leveraging its Cayman Islands (KY) registration for capital efficiency while targeting the growing demand for non-invasive dermatological treatments. The leadership of KL is currently consolidated under Wang Jia-Wei (王嘉瑋), who serves as both the Chairman of the Board and the General Manager. Wang assumed the dual role in late 2025 following a strategic management reorganization aimed at streamlining decision-making during the company’s transition into the biotech sector. Supporting the executive suite is Wu Jin-Xian (吳晉賢), who was appointed in March 2026 to the multi-functional role of Spokesperson, Chief Financial Officer, and Corporate Governance Officer. The board’s recent focus has been on stabilizing the company’s financial position following a period of R&D-heavy investment, as evidenced by the March 2026 approval of the fiscal year 2025 consolidated reports. While the company has faced recent operating losses, its leadership remains committed to expanding its footprint in the medical aesthetics supply chain, backed by a board of directors with deep expertise in cross-strait trade and industrial manufacturing.